Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
Clinical trial NCT01708629 · TERMINATED
Trial details
- NCT number
- NCT01708629
- Sponsor
- Bausch Health Americas, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2014-08-01
- Enrollment
- 1881
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.